SinoMab BioScience Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for SinoMab BioScience.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 35.7% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Update: SinoMab BioScience (HKG:3681) Stock Gained 21% In The Last Year
Mar 04
What You Need To Know About SinoMab BioScience Limited's (HKG:3681) Investor Composition
Jan 28Did SinoMab BioScience Limited (HKG:3681) Insiders Buy Up More Shares?
Jan 01
Loss-Making SinoMab BioScience Limited (HKG:3681) Expected To Breakeven In The Medium-Term
Nov 30In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SinoMab BioScience has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 4 | -243 | -134 | -134 | N/A |
| 9/30/2023 | 1 | -259 | -233 | -176 | N/A |
| 6/30/2023 | 5 | -274 | -332 | -218 | N/A |
| 3/31/2023 | 5 | -279 | -374 | -259 | N/A |
| 12/31/2022 | 4 | -284 | -415 | -301 | N/A |
| 9/30/2022 | 23 | -301 | -413 | -252 | N/A |
| 6/30/2022 | 34 | -318 | -412 | -204 | N/A |
| 3/31/2022 | 30 | -303 | -387 | -175 | N/A |
| 12/31/2021 | 27 | -288 | -362 | -147 | N/A |
| 9/30/2021 | 20 | -222 | -327 | -152 | N/A |
| 6/30/2021 | 13 | -156 | -292 | -156 | N/A |
| 3/31/2021 | 13 | -139 | -263 | -149 | N/A |
| 12/31/2020 | 13 | -123 | -234 | -141 | N/A |
| 9/30/2020 | 6 | -217 | -274 | -205 | N/A |
| 6/30/2020 | N/A | -311 | -315 | -270 | N/A |
| 3/31/2020 | N/A | -294 | -290 | -246 | N/A |
| 12/31/2019 | N/A | -276 | -265 | -222 | N/A |
| 12/31/2018 | 1 | -84 | -50 | -47 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 3681's forecast earnings growth is above the savings rate (2%).
Earnings vs Market: Insufficient data to determine if 3681's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 3681's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 3681's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 3681's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 3681's Return on Equity is forecast to be high in 3 years time